On the recordMay 21, 2013
And I think the fact that we have market-based pricing rather than government price controls is a significant part of the reason that that is the case.
Source
congress.govEditor's note · Context
Attributes U.S. pharmaceutical innovation to market-based pricing.
Share & report
More from Susan Collins
Feb 25, 2025
I'm very concerned about the impact on the state of Maine, on everything from our national parks to biomedical research. So this is a big problem.
Mar 3, 2025
I just think this is a matter of fairness, safety and giving girls and young women the opportunity to excel in sports.
Other voices in this conversation
